Ellen Rudolph is co-founder and CEO of WellTheory, the virtual care platform reversing the autoimmune epidemic. Launched in 2022, WellTheory was born out of Ellen's personal autoimmune journey and the gaps in traditional care encountered along the way. She is on a mission to empower the 50M+ Americans navigating autoimmune disease with education, community, and evidence-based, whole-person care. WellTheory has raised a total of $7.2M from Accel, Lux Capital, Box Group, Rock Health, and others.
Spending on prescription drugs for autoimmune diseases has increased by 459% over the past decade, even surpassing cancer drugs. Yet despite driving around 30% of employers’ entire prescription spend, autoimmune diseases have remained completely overlooked in employer health spend.